QS Investors’s Exelixis EXEL Stock Holding History

QS Investors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,323	Closed	-$198K	–	1295
2020 Q2	$198K	Hold	8,323	–	–	﹤0.01%	1137
2020 Q1	$144K	Hold	8,323	–	–	﹤0.01%	1162
2019 Q4	$147K	Hold	8,323	–	–	﹤0.01%	1266
2019 Q3	$148K	Sell	8,323 -99,447	-92%	-$2.01M	﹤0.01%	1278
2019 Q2	$2.3M	Buy	107,770 +10,618	+11%	+$223K	0.02%	534
2019 Q1	$2.31M	Buy	97,152 +33,362	+52%	+$761K	0.03%	546
2018 Q4	$1.25M	Sell	63,790 -72,355	-53%	-$1.29M	0.02%	708
2018 Q3	$2.41M	Sell	136,145 -6,159	-4%	-$120K	0.02%	562
2018 Q2	$3.06M	Hold	142,304	–	–	0.03%	464
2018 Q1	$3.15M	Buy	142,304 +126,764	+816%	+$3.5M	0.03%	414
2017 Q4	$472K	Hold	15,540	–	–	﹤0.01%	954
2017 Q3	$377K	Hold	15,540	–	–	﹤0.01%	1028
2017 Q2	$383K	Buy	15,540 +7,602	+96%	+$161K	﹤0.01%	1005
2017 Q1	$172K	Buy	7,938 +7,900	+20,789%	+$161K	﹤0.01%	1286
2016 Q4	$1K	Buy	+38	New	+$548	﹤0.01%	1587
2016 Q3	–	Sell	-34	Closed	-$1K	–	1948
2016 Q2	$1K	Buy	+34	New	+$196	﹤0.01%	1604
2016 Q1	–	Sell	-50	Closed	-$1K	–	2006
2015 Q4	$1K	Buy	+50	New	+$280	﹤0.01%	1620

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

QS Investors's EXEL Position: Q3 2020 in Review

QS Investors sold out of Exelixis (EXEL) in Q3 2020, closing a stake of 8,323 shares — an estimated $198K sold.

QS Investors first reported a position in EXEL in Q4 2015 and held it in 17 quarters. The position peaked at $3.15M in Q1 2018. 367 funds tracked by Wall St. Rank hold EXEL as of Q3 2020.

QS Investors reported no remaining Exelixis position as of Q3 2020 after selling out during the quarter.
QS Investors sold 8,323 Exelixis shares in Q3 2020, an estimated $198K.
QS Investors first reported a position in Exelixis in Q4 2015 and held it in 17 quarters.
QS Investors's Exelixis position peaked at $3.15M in Q1 2018.
367 funds tracked by Wall St. Rank held Exelixis as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.